Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Glaukos Corp (NY: GKOS ) 133.37 +4.12 (+3.19%) Official Closing Price Updated: 7:00 PM EDT, Oct 18, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Glaukos Corp < Previous 1 2 3 4 5 6 7 8 9 Next > Glaukos Announces Positive Topline Outcomes in Phase 3 Confirmatory Trial for Epioxa™, Achieving Primary Efficacy Endpoint and Demonstrating Favorable Tolerability and Safety October 16, 2024 From Glaukos Corporation Via Business Wire A Closer Look at 7 Analyst Recommendations For Glaukos October 14, 2024 Via Benzinga Glaukos To Present Multiple Scientific Abstracts at the 2024 American Academy of Ophthalmology Annual Meeting October 14, 2024 From Glaukos Corporation Via Business Wire Glaukos to Release Third Quarter 2024 Financial Results after Market Close on November 4 October 09, 2024 From Glaukos Corporation Via Business Wire Navigating 11 Analyst Ratings For Glaukos August 28, 2024 Via Benzinga Glaukos Stock: A Deep Dive Into Analyst Perspectives (12 Ratings) August 01, 2024 Via Benzinga Glaukos Announces Participation in Upcoming Investor Conferences August 16, 2024 From Glaukos Corporation Via Business Wire Meta To Rally Around 35%? Here Are 10 Top Analyst Forecasts For Thursday August 01, 2024 Via Benzinga GKOS Stock Earnings: Glaukos Misses EPS, Beats Revenue for Q2 2024 July 31, 2024 GKOS stock results show that Glaukos missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024. Via InvestorPlace Glaukos Announces Second Quarter 2024 Financial Results July 31, 2024 From Glaukos Corporation Via Business Wire 10 Analysts Have This To Say About Glaukos July 10, 2024 Via Benzinga Deep Dive Into Glaukos Stock: Analyst Perspectives (12 Ratings) May 22, 2024 Via Benzinga Analyst Ratings For Glaukos April 08, 2024 Via Benzinga 5 Analysts Have This To Say About Glaukos March 22, 2024 Via Benzinga 7 Leading MedTech Stocks for Next-Gen Health Solutions July 31, 2024 With healthcare innovations promising to deliver groundbreaking solutions, these MedTech stocks should be on your radar. Via InvestorPlace This Visa Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday July 10, 2024 Via Benzinga Glaukos to Release Second Quarter 2024 Financial Results after Market Close on July 31 July 10, 2024 From Glaukos Corporation Via Business Wire Glaukos Announces Agreements to Exchange $230 Million in Principal Amount of Its 2.75% Convertible Senior Notes Due 2027 for Common Stock June 14, 2024 From Glaukos Corporation Via Business Wire Glaukos: Q4 Earnings Insights February 21, 2024 Via Benzinga Glaukos Announces Participation in Upcoming Investor Conferences May 28, 2024 From Glaukos Corporation Via Business Wire Eye Disease-Focused Glaukos' 'Investor Interest Should Continue To Gain Momentum:' Analyst May 02, 2024 Glaukos reports Q1 adjusted EPS loss, sales beat estimates. Strong guidance for 2024 with positive analyst sentiment, driving stock up 6.22%. Via Benzinga Topics Earnings Exposures Financial C.H. Robinson Worldwide Posts Upbeat Results, Joins Avis Budget Group, Qualcomm, BorgWarner, Moderna And Other Big Stocks Moving Higher On Thursday May 02, 2024 Via Benzinga GKOS Stock Earnings: Glaukos Misses EPS, Beats Revenue for Q1 2024 May 01, 2024 GKOS stock results show that Glaukos missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024. Via InvestorPlace Glaukos Announces First Quarter 2024 Financial Results May 01, 2024 From Glaukos Corporation Via Business Wire Glaukos Announces the Release of its 2023 Sustainability Report April 16, 2024 From Glaukos Corporation Via Business Wire Glaukos to Release First Quarter 2024 Financial Results after Market Close on May 1 April 10, 2024 From Glaukos Corporation Via Business Wire Signet Jewelers, Dave & Buster's Entertainment, Blue Owl Capital And Other Big Stocks Moving Higher On Wednesday April 03, 2024 U.S. stocks were higher, with the Dow Jones gaining over 50 points on Wednesday. Via Benzinga Topics Stocks Exposures US Equities Glaukos Receives Permanent J-code for iDose® TR (travoprost intracameral implant) April 03, 2024 From Glaukos Corporation Via Business Wire Glaukos To Present Numerous Scientific Abstracts at the 2024 American Society of Cataract and Refractive Surgery Annual Meeting April 01, 2024 From Glaukos Corporation Via Business Wire Analog Devices To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Thursday February 22, 2024 Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Via Benzinga < Previous 1 2 3 4 5 6 7 8 9 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.